United States · FDA National Drug Code directory
Tobramycin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70700-173_4b807769-4cf0-f110-e063-6294a90ac6a7
- Product NDC
- 70700-173
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Composition / generic term
- Tobramycin
- Labeler
- Xiromed LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210712
- Source listing expiry
- 20271231
Source-listed ingredients
- TOBRAMYCIN SULFATE — 1.2 g/30mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-22) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE · 70700-173-22
- 6 VIAL, PHARMACY BULK PACKAGE in 1 CARTON (70700-173-86) / 50 mL in 1 VIAL, PHARMACY BULK PACKAGE · 70700-173-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →